Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

Business Leaders

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors 
HomeAll NewsMost read newsBusiness Leaders Biography
Portrait de Albert Bourla
Age : 59
Public asset : 8,685,653 USD
Country of residence : Unknown
Linked companies : Pfizer Inc.

Biography of Albert Bourla 
Albert Bourla is Chairman, Chief Executive & Operating Officer at Pfizer Inc., Member of The Business Roundtable and Member of The Business Council and on the board of 7 other companies. Dr. Bourla received a doctorate from School of Veterinary Medicine (Greece).


Current positions of Albert Bourla 
Holdings of Albert Bourla 
Albert Bourla : Personal Network 
Most Read News 
09/26Unilever's soap opera: M&A, Nelson Peltz, CEO to retire
RE
09/20JPMorgan CEO Dimon to warn Congress of economic 'storm clouds' -testimony
RE
09/28Buffett's Berkshire Hathaway buys 5.99 million more Occidental shares
RE
09/14Package that exploded in Boston had note critical of Meta's Zuckerberg, CNN reports
RE
09/26Twitter to interview Elon Musk, known for combative testimony
RE
09/21Trump ally Barrack's trial on foreign agent charges moves to opening statements
RE
09/20Palihapitiya to wind down two blank-check firms as choppy markets deter valuations
RE
09/21Bloomberg to spend $85 million against U.S. plastic, petrochem buildout
RE
09/28Elon Musk seeks to narrow SEC consent decree, end pre-approval of tweets
RE
09/15Elon Musk accuses Twitter of security lapses in court filing
RE
More news


© 2022 People and Ownership :   
Albert Bourla : Connections 


Latest news about Albert Bourla 
09/24Pfizer CEO tests positive for COVID
RE
09/15Lawsuit claims Pfizer fellowship program is biased against whites, Asian-Americans
RE
08/24Transcript : Pfizer Inc. - Special Call
CI
08/24Transcript : Pfizer Inc. Presents at Handelsbanken Life Science Innovation Day 2022, Aug-24-2022 10:30 AM
CI
08/22Pfizer, BioNTech Seek FDA Approval for Updated COVID-19 Booster Shot Targeting New Omicron Subvariants
MT
More news